You are here

gene therapy

Gene therapy biotechs caught in manufacturing crunch

Gene therapy biotechs caught in manufacturing crunch

Biopharma Dive

drug manufacturing

Flag link:

How Express Scripts Plans to Disrupt the Emerging Cell and Gene Therapy Channel

How Express Scripts Plans to Disrupt the Emerging Cell and Gene Therapy Channel

Drug Channels

Express Scripts

Flag link:

Prevail and Lonza Deepen Partnership with New Collaboration

Prevail and Lonza Deepen Partnership with New Collaboration

BioSpace

Prevail Therapeutics

baculovirus/Sf9 expression

neurodegenerative disease

Flag link:

FDA leaders worry agency will lose out on talent in gene therapy, cancer fields

FDA leaders worry agency will lose out on talent in gene therapy, cancer fields

Biopharma Dive

Flag link:

Sarepta, in shadow of FDA setback, marks gene therapy progress

Sarepta, in shadow of FDA setback, marks gene therapy progress

BioPharma Dive

Sarepta Therapeutics

limb-girdle muscular dystrophy

muscular dystrophy

Flag link:

Gene therapy stocks have taken a beating. Their recovery may be slow

Gene therapy stocks have taken a beating. Their recovery may be slow

BioSpace

Flag link:

After failed cancer test, Tocagen slashes staff

After failed cancer test, Tocagen slashes staff

Fierce Biotech

Flag link:

Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO

Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO

CP Wire

4D Molecular Therapeutics

Flag link:

Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO

Gene therapy startup Passage Bio nabs Janssen neuro lead as CMO

Fierce Biotech

Flag link:

bluebird presents long-term data from CALD gene therapy

bluebird presents long-term data from CALD gene therapy

Pharmaforum

Flag link:

This Company Is Looking to Win Big in Gene Therapy

This Company Is Looking to Win Big in Gene Therapy

Motley Fool

drug manufacturing

Flag link:

Early snapshot of Adverum's eye gene therapy sparks concern about vision loss

Early snapshot of Adverum's eye gene therapy sparks concern about vision loss

Endpoints

Adverum Biotechnologies

wet age-related macular degeneration

Flag link:

BioMarin talks down worries on gene therapy data differences

BioMarin talks down worries on gene therapy data differences

Biopharma Dive

Flag link:

Italian gene therapy player draws new investor from China for its answer to CAR-T relapses

Italian gene therapy player draws new investor from China for its answer to CAR-T relapses

Endpoints

Genenta Science

clinical trials

Multiple Myeloma

Flag link:

Cigna rolls out plan to fully cover expensive gene therapies

Cigna rolls out plan to fully cover expensive gene therapies

Beckers Hospital Review

Flag link:

Ultragenyx gene therapy data disappoints investors

Ultragenyx gene therapy data disappoints investors

Biopharma Dive

glycogen storage disorder

clinical trials

Flag link:

Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B

Plotting clinical entry, James Wilson's gene therapy startup brings in billionaire for $110M Series B

Endpoints

Access Biotechnology

Flag link:

UK cost watchdog recommends Novartis' blindness therapy Luxturna

UK cost watchdog recommends Novartis' blindness therapy Luxturna

Yahoo/Reuters

Spark Therapeutics

Flag link:

UniQure stays a step ahead in hemophilia B

UniQure stays a step ahead in hemophilia B

Biopharma Dive

clinical trials

Flag link:

Pfizer injects $500M more into gene therapy manufacturing

Pfizer injects $500M more into gene therapy manufacturing

Biopharma Dive

drug manufacturing

Flag link:

Pages